| Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses M Hatta, P Gao, P Halfmann, Y Kawaoka Science 293 (5536), 1840-1842, 2001 | 1715 | 2001 |
| Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus D Kobasa, SM Jones, K Shinya, JC Kash, J Copps, H Ebihara, Y Hatta, ... Nature 445 (7125), 319-323, 2007 | 1344 | 2007 |
| Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ... Nature 602 (7898), 664-670, 2022 | 1100 | 2022 |
| Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development M Imai, K Iwatsuki-Horimoto, M Hatta, S Loeber, PJ Halfmann, ... Proceedings of the National Academy of Sciences 117 (28), 16587-16595, 2020 | 991 | 2020 |
| SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo YJ Hou, S Chiba, P Halfmann, C Ehre, M Kuroda, KH Dinnon III, SR Leist, ... Science 370 (6523), 1464-1468, 2020 | 939 | 2020 |
| Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus D Kobasa, A Takada, K Shinya, M Hatta, P Halfmann, S Theriault, ... Nature 431 (7009), 703-707, 2004 | 892 | 2004 |
| An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost, JE Crowe Jr, LA Purcell, ... Nature medicine 28 (3), 490-495, 2022 | 706 | 2022 |
| Transmission of SARS-CoV-2 in domestic cats PJ Halfmann, M Hatta, S Chiba, T Maemura, S Fan, M Takeda, ... New England Journal of Medicine 383 (6), 592-594, 2020 | 554 | 2020 |
| Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner A Nanbo, M Imai, S Watanabe, T Noda, K Takahashi, G Neumann, ... PLoS pathogens 6 (9), e1001121, 2010 | 488 | 2010 |
| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 487 | 2022 |
| Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (10), 995-998, 2022 | 359 | 2022 |
| Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2 E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (15), 1475-1477, 2022 | 282 | 2022 |
| Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants E Takashita, S Yamayoshi, V Simon, H Van Bakel, EM Sordillo, A Pekosz, ... New England Journal of Medicine 387 (5), 468-470, 2022 | 270 | 2022 |
| Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle ZA Bornholdt, T Noda, DM Abelson, P Halfmann, MR Wood, Y Kawaoka, ... Cell 154 (4), 763-774, 2013 | 256 | 2013 |
| Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2 R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ... Nature 607 (7917), 119-127, 2022 | 215 | 2022 |
| A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus BM Gunn, WH Yu, MM Karim, JM Brannan, AS Herbert, AZ Wec, ... Cell host & microbe 24 (2), 221-233. e5, 2018 | 211 | 2018 |
| Efficacy of antiviral agents against omicron subvariants BQ. 1.1 and XBB M Imai, M Ito, M Kiso, S Yamayoshi, R Uraki, S Fukushi, S Watanabe, ... New England Journal of Medicine 388 (1), 89-91, 2023 | 194 | 2023 |
| Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection EO Saphire, SL Schendel, ML Fusco, K Gangavarapu, BM Gunn, AZ Wec, ... Cell 174 (4), 938-952. e13, 2018 | 189 | 2018 |
| The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses EI Pécheur, V Borisevich, P Halfmann, JD Morrey, DF Smee, M Prichard, ... Journal of virology 90 (6), 3086-3092, 2016 | 181 | 2016 |
| Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters K McMahan, V Giffin, LH Tostanoski, B Chung, M Siamatu, MS Suthar, ... Med 3 (4), 262-268. e4, 2022 | 173 | 2022 |
